Hemoglobin-based oxygen carrier distribution inside vascular wall and arterial pressure evolution: Is there a relationship?

European Surgical Research

Volumn 37, Issue 1, 2005, Pages 1-8

  Smani, Y ^a   Faivre, Béatrice ^a   Audonnet Blaise, Sandra ^a   Labrude, P ^a   Vigneron, C ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Hemoglobin distribution; Hemoglobin based oxygen carrier; Hypertension; Isovolemic exchange transfusion

Indexed keywords

HEMOGLOBIN; OXYGEN;

ABDOMINAL AORTA; ANESTHESIA; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL WALL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GUINEA PIG; HYPERTENSION; INTIMA; ISOVOLEMIC EXCHANGE TRANSFUSION; MALE; NONHUMAN; OXYGEN TRANSPORT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRANSFUSION; VASA VASORUM;

ANIMALS; AORTA, ABDOMINAL; BLOOD PRESSURE; BLOOD SUBSTITUTES; DEXTRANS; ENDOTHELIAL CELLS; GUINEA PIGS; HEMATOCRIT; HEMOGLOBINS; KINETICS; MALE; MICROSCOPY, CONFOCAL; TIME FACTORS; TISSUE DISTRIBUTION; TUNICA INTIMA; VASA VASORUM;

EID: 17844396000     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083141     Document Type: Article

References (42)

1. Klein HG: The prospects for red-cell substitutes. N Engl J Med 2000;342:1666-1668.
2. Reid TJ: Hb-based oxygen carriers: Are we there yet? Transfusion 2003;43:280-287.
3. Saxena R, Wijnhoud AD, Carton H, Hacke W, Kaste M, Przybelski RJ, Stern KN, Koudstaal PJ: Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke 1999;30:993-996.
4. Sloan EP, Koenigsberg M, Gens D, Cipolle M, Runge J, Mallory MN, Rodman G Jr: Diasparin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: A randomized controlled efficacy trial. J Am Med Assoc 1999;282:1857-1864.
5. Squires JE: Artificial blood. Science 2002;8:1002-1005.
6. Gulati A, Sen AP, Sharma AC, Singh G: Role of ET and NO in resuscitative effect of diaspirin cross-linked hemoglobin after hemorrhage in rat. Am J Physiol Heart Circ Physiol 1997;273:H827-H836.
7. Reah G, Bodenham AR, Mallick A, Daily EK, Przybelski RJ: Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients. Crit Care Med 1997;25:1480-1488.
8. Rohlfs RJ, Bruner E, Chiu A, Gonzales A, Gonzales ML, Magde D, Magde MD, Vandegriff KD, Winslow RM: Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J Biol Chem 1998;273:12128-12134.
9. Masaki T: Endothelin in vascular biology. Ann NY Acad Sci 1994, 714:101-108.
10. Moncada S, Palmer RM, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
11. Rubanyi, GM, Polokoff MA: Endothelins: Molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev 1994;46:325-415.
12. Doherty DH, Doyle MP, Curry SR., Vali RJ, Fattor TJ, Olsen JS, Lemon DD: Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat Biotechnol 1998;16:672-676.
13. Kavdia M, Nikolaos MT, Popel AS: Model of nitric oxide diffusion in an arteriole: Impact of hemoglobin-based blood substitutes. Am J Physiol Heart Circ Physiol 2002;282:H2245-H2253.
14. Reiter DC, Wang X, Tanus-Santos JE, Hogg N, Cannon III RO, Schechter AN, Gladwin MT: Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002;8:1383-1389.
15. Cocks TM, Malta E, King SJ, Woods RL, Angus JA: Oxyhaemoglobin increases the production of endothelin-1 by endothelial cells in culture. Eur J Pharmacol 1991;196:177-182.
16. Lin G, Macdonald RL, Marton LS, Kowalczuk A, Solenski NJ, Weir BK: Hemoglobin increases endothelin-1 in endothelial cells by decreasing nitric oxide. Biochem Biophys Res Commun 2001;280:824-830.
17. Ohlstein EH, Storer BL: Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg 1992;77:274-278.
18. Nakai K, Toshio O, Sakuma I, Akama K, Kobayashi Y, Tokuyama S, Kitabatake A, Nakazato Y, Takahashi TA, Sadayoshi S: Inhibition of endothelium-dependent relaxation by hemoglobin in rabbit aortic strips: Comparison between acellular hemoglobin derivatives and cellular hemoglobins. J Cardiovasc Pharmacol 1996;28:115-123.
19. Foley PL, Kassell NF, Hudson B, Lee KS: Hemoglobin penetration in the wall of the rabbit basilar artery after subarachnoid hemorrhage and intracisternal hemoglobin injection. Acta Neurochir (Wien) 1993;123:82-86.
20. Machi T, Kassell NF, Tanaka Y, Hudson S, Lehman GA, Harrison PT: Hemoglobin damages the cultured endothelial cell monolayer from bovine cerebral arteries. Fukuoka Igaku Zasshi 1996;87:189-196.
21. Prouchayret F, Fasan G, Grandgeorge M, Vigneron C, Menu P, Dellacherie E: A potential blood substitute from carboxylic dextran and oxyhemoglobin. I. Preparation, purification and characterisation; in Chang TMS (ed): Blood Substitutes and Oxygen Carriers. New York, Dekker, 1993, pp 144-147.
22. Zhao SP, Cai HW, Liu ZS, Yang HW, Yang YY: Intraoperative application of acute normovolemic hemodilution. Hua Xi Yi Ke Da Xue Xue Bao 2000;25:83-84.
23. Fuwa I, Mayberg M, Gadjusek C, Harada T, Luo Z: Enhanced secretion of endothelin by endothelial cells in response to hemoglobin. Neurol Med Chir (Tokyo) 1993;33:739-743.
24. Rioux F, Harvey N, Moisan S, Larivière R, Lebel M, Grose JH, Burhop K: Nonpeptide endothelin receptor antagonists attenuate the pressure effect of diaspirin-crosslinked hemoglobin in rat. Can J Physiol Pharmacol 1999; 77:188-194.
25. Saxena R, Winjnhoud AD, Man in't Veld AJ, van den Meiracker AH, Boomsma F, Pryzbzlski RJ, Koudstaal PJ: Effect of diaspirin cross-linked hemoglobin on endothelin and blood pressure in acute ischemic stroke in man. J Hypertense 1998;16:1459-1465.
26. Schultz SC, Grady B, Cole F, Hamilton I, Burhop K, Malcolm DS: A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993;122:301-308.
27. Sharma AC, Gulati A: Yohimbine modulates diaspirin crosslinked hemoglobin-induced systemic hemodynamics and regional circulatory effects. Crit Care Med 1995;23:801-804.
28. Fizpatrick CM, Savage SA, Kerby JD, Clouse WD, Kashyap VS: The effects of resuscitation with a blood substitute on vasomotor physiology in a swine model of arterial hemorrhage. J Surg Res 2003;114:247-248.
29. Jia Y, Wood F, Menu P, Faivre B, Caron A, Alayash AI: Oxygen binding and oxidation reactions of human hemoglobin conjugated to carboxylate dextran. Biochim Biophy Acta 2004;1672:164-173.
30. Caron A, Menu P, Faivre-Fiorina B, Labrude P, Alayash AI, Vigneron C: Cardiovascular and hemorheological effects of three modified human hemoglobin solutions in hemodiluted rabbits. J Appl Physiol 1999;86:541-548.
31. Caron A, Menu P, Faivre-Fiorina B, Labrude P, Vigneron C: The effects of stroma-free and dextran-conjugated hemoglobin on hemodynamics and carotid blood flow in hemorrhaged guinea pigs. Artif Cells Blood Substit Immobil Biotechnol 1999;27:49-64.
32. Caron A, Menu P, Labrude P, Vigneron C: Proposition of a technique to assess the vasoactive effects of hemoglobin-based oxygen carrying solutions in vivo: Preliminary results in the rabbit aorta. Artif Cells Blood Substit Immobil Biotechnol 1998;26:293-308.
33. Dunlap E, Farrell L, Nigro C, Estep T, Marchand G, Burhop K: Resuscitation with diaspirin crosslinked hemoglobin in a pig model of hemorrhagic shock. Artif Cells Blood Substit Immobil Biotechnol 1995;23:39-61.
34. Hess JR, MacDonald VW, Brinkley WW: Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 1993;74:1769-1778.
35. Caron A, Mayer JC, Menu P, Alayash A, Marie PY, Vigneron C: Measurement of blood volume after haemodilution with haemoglobin-based oxygen carriers by a radiolabelled-albumin method. Transfus Med 2001;11:433-442.
36. Fischer SR, Burnet M, Traber DL, Prough DS, Kramer GC: Plasma volume expansion with solutions of hemoglobin, albumin, and Ringer lactate in sheep. Am J Physiol Heart Circ Physiol1999;276:H2194-H2203.
37. Olson JS, Foley EW, Roggie C, Tsai AL, Doyle MP, Lemon DD: NO scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic Biol Med 2004;36:685-697.
38. Faivre-Fiorina B, Caron A, Fassot C, Fries I, Menu P, Labrude P, Vigneron C: Presence of hemoglobin inside aortic endothelial cells after cell-free hemoglobin administration in guinea pigs. Am J Physiol Heart Circ Physiol 1999; 276:H766-H770.
39. Migita R, Gonzales A, Gonzales ML, Vandegriff KD, Winslow RM: Blood volume and cardiac index in rats after exchange transfusion with hemoglobin-based oxygen carriers. J Appl Physiol 1997;82:1995-2002.
40. Milici AJ, Bankston PW: Fetal and neonatal rat intestinal capillaries: Permeability to carbon, ferritin, hemoglobin, and myoglobin. Am J Anat 1982;165:165-186.
41. Bleeker WK, Van Der Plas J, Freitsma RIJ, Agterberg J, Reigter G, De Vries-van Rossen A: In vivo distribution and elimination of hemoglobin modified by intramolecular cross-linking with 2-nor-2-formylpyridoxal 5′-phosphate. J Lab Clin Med 1989;113:151-161.
42. Baldwin AL: Blood substitutes and the intestinal microcirculation: Extravasation and structural alterations; in Winslow RM, Vandegriff KD, Intaglietta M (eds): Advances in Blood Substitutes: Industrial Opportunities and Medical Challenges. Boston, Birkhäuser, 1997, pp 19-37.